Robert Dreicer, MD, MS, MACP, FASCO - Decisions and Dilemmas in Prostate Cancer Management: Building on Progress to Advance Personalized Care Through Candid Conversations and Expert Clinical Consults

Robert Dreicer, MD, MS, MACP, FASCO - Decisio...

Up next

Jonathan L. Kaufman, MD - On Track for Remission in Multiple Myeloma: Modern Off-the-Shelf Choices for Effective and Accessible Care in Relapsed/Refractory Disease

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE infor ...  Show more

Barrett Craig Lawson, MD, Joyce Liu, MD, MPH - Powering Pathology Precision: Expert Strategies for Folate Receptor Alpha Testing to Guide Personalized ADC Care in Advanced Ovarian Cancer

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, ...  Show more

Recommended Episodes

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Prostate Cancer
Prostate Cancer Update

Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with prostate cancer. 

Advances in ADT: A Guide for Urologists and APPs
AUAUniversity

Advances in ADT: A Guide for Urologists and APPs CME Available: https://auau.auanet.org/node/37866 At the conclusion of this activity, participants will be able to: 1. Identify and treat a patient with new diagnosed M1 prostate cancer with ADT plus be able to offer additional the ...  Show more

Early-Stage Prostate Cancer: Know Your Treatment Options
Cancer Straight Talk

Learn what you need to know about early-stage prostate cancer, from risk factors to treatment options and how to tackle their side effects. In this episode, Dr. Diane Reidy-Lagunes is joined by medical oncologist Dr. Dana Rathkopf, radiation oncologist Dr. Sean McBride, and urolo ...  Show more

Melissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
PeerView Internal Medicine CME/CNE/CPE Audio Podcast

Go online to PeerView.com/ANP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The treatment arsenal for NSCLC with and without genomic alterations is continuously growing, and novel HER2-, HER3-, and TROP2-targeting antibody– ...  Show more